MENU

FIND DOCTORS

Name: Lu, Renquan
Department: CLINICAL LABORATORY
Title:Associate Senior Technologist

 
 
 
Education & Professional Experience   2012.12-Present: Associate Senior Technologist, Department of Clinical Laboratory, Fudan University Shanghai Cancer Cancer/Department of Oncology, Fudan University Shanghai Cancer Cancer. 
2011.09-2012.09: Visiting scholar, Department of Oncology, Havard Medical School (HMS),USA.
2009.09-2012.12, PhD, Major: Biochemistry and Molecular Biology, Fudan University Shanghai Medical School. 
2007.06-2012.12: Technologist-in-charge, Department of Clinical Laboratory, Fudan University Cancer Hospital.
2004.09-2007.06, MS, Major: Clinical Laboratory Diagnostics, Department of Laboratory Medicine, Shanghai Jiaotong University Medical School. 
1999.07-2004.08: Technologist-in-charge/Assistant researcher, Shanghai Bencao Biomedical Institute.
1994.09-1999.07, BS, Major: Laboratory Medicine, Department of Laboratory Medicine, Jiangsu University Medical School.

 
 
Specialty   Clinical oncology research/ Translational Medicine
 
 
Research   Biomarkers, ovarian cancer, gastric cancer, esophageal cancer
 
 
Publication   1. Lu RQ, Pal J, Buon L, Nanjappa P, Shi JL, Fulciniti M, Guo L, Yu M, Munshi NC, Shammas MA. Targeting homologous recombination and telomerase in Barrett’s adenocarcinoma: Impact on telomere maintenance, genomic instability, and tumor growth. Oncogene 2013; accepted.
2. Lu RQ, Wu CS, Guo L, Liu YC, Mo W, Wang HJ, Ding JB, Wong ET, Yu M. The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo. BMC Cancer 2012; 12: 607.
3. Lu RQ, Sun XH, Xiao R, Zhou L, Gao X, Guo L. Human Epididymis Protein 4 (HE4) Plays a Key Role in Ovarian Cancer Cell Adhesion and Motility. Biochemical Biophysical Research Communications 2012; 419(2): 274-280.
4. Lu RQ, Yang DP, Cui DX, Guo L. Egg-white mediated Green synthesis of Silver Nanoparticles with excellent biocompatibility and Enhanced Radiation Effects on Cancer Cells. International Journal of Nanomedicine 2012; 7: 2101-2107.
5. Lu RQ, Dou XW, Gao X, Zhang J, Ni J, Guo L. A functional polymorphism of lymphotoxin-alpha (LTA) gene rs909253 is associated with gastric cancer risk in an Asian population. Cancer Epidemiology 2012; 36(6): e380-386.
6. Lu RQ, Gao X, Chen Y, Li S, Ni J, Guo L. Association of an NF-kappaB1 intron SNP (rs4648068) with gastric cancer patients in Chinese Han population. BMC gastroenterology 2012; 12: 87.
7. Lu RQ, Sun M, Feng JJ, Gao X, Guo L. Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer, BMC Cancer 2011, 11: 270.
8. Shen YH, Lu RQ, Guo L. Clinical Value of Urinary Iodine Determination in Screening for Thyroid Tumor. China Cancer 2011, 20(9): 699-702.
9. Lu RQ, Guo L, Shen YH. The value of human epididymis protein 4 in patients with ovarian cancer. China Oncology 2010, 20(9): 585- 590.
10. Lu RQ, Hu J,Guo L. Studier on the value of human epididymis protein 4 in patients with ovarian cancer. Chinese Journal Laboratory Medicine 2009, 32(12): 1379-1383.
11. Lu RQ, Zheng ZY,Guo L. Development of a gold immunochromatographic assay reagent for rapid detection of alpha-fetoprotein and carcinoembryonic antigen and evaluation of its performance. Laboratory Medicine 2009, 24(12): 899- 903.


Patents: 2012; “Development of the kit for human plasma tumor type-M2 pyruvate kinase concentration and its preparation” Authorized No.: ZL 2008 1 0033501.4.
 
 
Awards   2012 “Establishment of the immunoassay for human plasma MR-1 concentration and its preparation” [Excellent Invention, Silver Award]; The Excellent Invention competetion Commission of Shanghai Municipality;
2009 “Development of the kit for human plasma tumor type-M2 pyruvate kinase concentration and its preparation” [Excellent Invention, Bronze Award]; The Excellent Invention competetion Commission of Shanghai Municipality